Ibbott GS - Search Results

1

Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy.

Frank SJ, Tailor RC, Kudchadker RJ, Martirosyan KS, Stafford RJ, Elliott AM, Swanson DA, Sing D, Choi J, Mourtada F, Ibbott GS. Frank SJ, et al. Among authors: ibbott gs. Med Dosim. 2011 Summer;36(2):200-5. doi: 10.1016/j.meddos.2010.03.004. Epub 2010 May 26. Med Dosim. 2011. PMID: 20537886

2

Dosimetric characteristics of a new 125I brachytherapy source.

Gearheart DM, Drogin A, Sowards K, Meigooni AS, Ibbott GS. Gearheart DM, et al. Among authors: ibbott gs. Med Phys. 2000 Oct;27(10):2278-85. doi: 10.1118/1.1290486. Med Phys. 2000. PMID: 11099194

3

TG-51: experience from 150 institutions, common errors, and helpful hints.

Tailor RC, Hanson WF, Ibbott GS. Tailor RC, et al. Among authors: ibbott gs. J Appl Clin Med Phys. 2003 Spring;4(2):102-11. doi: 10.1120/jacmp.v4i2.2524. J Appl Clin Med Phys. 2003. PMID: 12777144 Free PMC article.

4

Predictability of electron cone ratios with respect to linac make and model.

Tailor RC, Followill DS, Hernandez N, Ibbott GS, Hanson WF. Tailor RC, et al. Among authors: ibbott gs. J Appl Clin Med Phys. 2003 Spring;4(2):172-8. doi: 10.1120/jacmp.v4i2.2534. J Appl Clin Med Phys. 2003. PMID: 12777153 Free PMC article.

5

Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry.

Gifford KA, Horton JL Jr, Jackson EF, Steger TR 3rd, Heard MP, Mourtada F, Lawyer AA, Ibbott GS. Gifford KA, et al. Among authors: ibbott gs. Med Phys. 2005 Jul;32(7):2288-94. doi: 10.1118/1.1944247. Med Phys. 2005. PMID: 16121584

6

Consistency of absorbed dose to water measurements using 21 ion-chamber models following the AAPM TG51 and TG21 calibration protocols.

Tailor RC, Hanson WF, Wells N, Ibbott GS. Tailor RC, et al. Among authors: ibbott gs. Med Phys. 2006 Jun;33(6):1818-28. doi: 10.1118/1.2199598. Med Phys. 2006. PMID: 16872089

7

Dose specification and quality assurance of radiation therapy oncology group protocol 95-17; a cooperative group study of iridium-192 breast implants as sole therapy.

Ibbott GS, Hanson WF, O'Meara E, Kuske RR, Arthur D, Rabinovitch R, White J, Wilenzick RM, Harris I, Tailor RC. Ibbott GS, et al. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1572-8. doi: 10.1016/j.ijrobp.2007.08.011. Int J Radiat Oncol Biol Phys. 2007. PMID: 18035213 Free PMC article. Clinical Trial.

8

Thermoluminescence dosimetry measurements of brachytherapy sources in liquid water.

Tailor R, Tolani N, Ibbott GS. Tailor R, et al. Among authors: ibbott gs. Med Phys. 2008 Sep;35(9):4063-9. doi: 10.1118/1.2968097. Med Phys. 2008. PMID: 18841858

9

Dosimetric characterization of a 131Cs brachytherapy source by thermoluminescence dosimetry in liquid water.

Tailor R, Ibbott G, Lampe S, Warren WB, Tolani N. Tailor R, et al. Med Phys. 2008 Dec;35(12):5861-8. doi: 10.1118/1.3020754. Med Phys. 2008. PMID: 19175142

10

Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the (125)I I-Seed AgX100 source model.

Mourtada F, Mikell J, Ibbott G. Mourtada F, et al. Brachytherapy. 2012 May-Jun;11(3):237-44. doi: 10.1016/j.brachy.2011.06.002. Epub 2011 Aug 3. Brachytherapy. 2012. PMID: 21816684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page